These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3849581)

  • 21. Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load.
    Buturović-Ponikvar J; Pernat AM; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):258-61. PubMed ID: 15967002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing the hemorrhagic complications of hemodialysis: a controlled comparison of low-dose heparin and citrate anticoagulation.
    Flanigan MJ; Von Brecht J; Freeman RM; Lim VS
    Am J Kidney Dis; 1987 Feb; 9(2):147-53. PubMed ID: 3548336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional sodium citrate anticoagulation in patients with active bleeding undergoing hemodialysis.
    Ashouri OS
    Uremia Invest; 1985-1986; 9(1):45-51. PubMed ID: 3835743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple and novel technique for regional citrate anticoagulation during intermittent hemodialysis may obviate the need for calcium monitoring.
    Robert T; Bureau C; Lebourg L; Rondeau E; Petitclerc T; Ridel C
    Intensive Care Med; 2017 Dec; 43(12):1927-1928. PubMed ID: 28916999
    [No Abstract]   [Full Text] [Related]  

  • 25. Citrate versus heparin anticoagulation in chronic haemodialysis patients.
    Janssen MJ; Huijgens PC; Bouman AA; Oe PL; Donker AJ; van der Meulen J
    Nephrol Dial Transplant; 1993; 8(11):1228-33. PubMed ID: 8302461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-Free Regional Anticoagulation: There Are Significant Differences Between Citrate-Containing Dialysate and Regional Citrate Anticoagulation.
    Gubensek J; Buturovic-Ponikvar J
    Crit Care Med; 2018 Feb; 46(2):e176-e177. PubMed ID: 29337813
    [No Abstract]   [Full Text] [Related]  

  • 27. Citrate regional anticoagulation in haemodialysis.
    Hocken AG; Hurst PL
    Nephron; 1987; 46(1):7-10. PubMed ID: 3600914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge.
    Gabutti L; Marone C; Colucci G; Duchini F; Schönholzer C
    Intensive Care Med; 2002 Oct; 28(10):1419-25. PubMed ID: 12373466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury.
    Durão MS; Monte JC; Batista MC; Oliveira M; Iizuka IJ; Santos BF; Pereira VG; Cendoroglo M; Santos OF
    Crit Care Med; 2008 Nov; 36(11):3024-9. PubMed ID: 18824904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status.
    Morgera S; Schneider M; Slowinski T; Vargas-Hein O; Zuckermann-Becker H; Peters H; Kindgen-Milles D; Neumayer HH
    Crit Care Med; 2009 Jun; 37(6):2018-24. PubMed ID: 19384210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of severe hypercalcemia using continuous renal replacement therapy with regional citrate anticoagulation.
    Kindgen-Milles D; Kram R; Kleinekofort W; Morgera S
    ASAIO J; 2008; 54(4):442-4. PubMed ID: 18645366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Citrate anticoagulation for hemodialysis patients at risk of bleeding.
    Collart FE; Tielemans CL; Wens R; Dratwa M
    Am J Nephrol; 1989; 9(3):263-4. PubMed ID: 2757082
    [No Abstract]   [Full Text] [Related]  

  • 34. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
    Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D
    Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration.
    Hetzel GR; Taskaya G; Sucker C; Hennersdorf M; Grabensee B; Schmitz M
    Am J Kidney Dis; 2006 Nov; 48(5):806-11. PubMed ID: 17060000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulation and continuous renal replacement therapy.
    Amanzadeh J; Reilly RF
    Semin Dial; 2006; 19(4):311-6. PubMed ID: 16893409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation.
    Apsner R; Hörl WH; Sunder-Plassmann G
    Blood; 2001 May; 97(9):2914-5. PubMed ID: 11345088
    [No Abstract]   [Full Text] [Related]  

  • 38. Regional citrate anticoagulation for hemodialysis following cardiovascular surgery.
    Lohr JW; Slusher S; Diederich DA
    Am J Nephrol; 1988; 8(5):368-72. PubMed ID: 3071143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional citrate anticoagulation--finally on its way to standardization?
    Joannidis M
    Crit Care Med; 2009 Jun; 37(6):2128-9. PubMed ID: 19448471
    [No Abstract]   [Full Text] [Related]  

  • 40. A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: the 'Modified Alabama Protocol'.
    Davies H; Morgan D; Leslie G
    Aust Crit Care; 2008 Aug; 21(3):154-65. PubMed ID: 18635373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.